|
1AYP
A PROBE MOLECULE COMPOSED OF SEVENTEEN PERCENT OF TOTAL DIFFRACTING MATTER GIVES CORRECT SOLUTIONS IN MOLECULAR REPLACEMENT
提交 1994-07-19
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
21–144(124 aa)
链 F
21–144(124 aa)
|
未记录
|
CA CALCIUM ION × 4
INB 1-OCTADECYL-2-ACETAMIDO-2-DEOXY-SN-GLYCEROL-3-PHOSPHOETHYLMETHYL SULFIDE × 2
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 2.57 Å
|
|
1AYP
A PROBE MOLECULE COMPOSED OF SEVENTEEN PERCENT OF TOTAL DIFFRACTING MATTER GIVES CORRECT SOLUTIONS IN MOLECULAR REPLACEMENT
提交 1994-07-19
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 B
21–144(124 aa)
链 E
21–144(124 aa)
|
未记录
|
CA CALCIUM ION × 4
INB 1-OCTADECYL-2-ACETAMIDO-2-DEOXY-SN-GLYCEROL-3-PHOSPHOETHYLMETHYL SULFIDE × 2
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 2.57 Å
|
|
1AYP
A PROBE MOLECULE COMPOSED OF SEVENTEEN PERCENT OF TOTAL DIFFRACTING MATTER GIVES CORRECT SOLUTIONS IN MOLECULAR REPLACEMENT
提交 1994-07-19
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 3
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 C
21–144(124 aa)
链 D
21–144(124 aa)
|
未记录
|
CA CALCIUM ION × 4
INB 1-OCTADECYL-2-ACETAMIDO-2-DEOXY-SN-GLYCEROL-3-PHOSPHOETHYLMETHYL SULFIDE × 2
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 2.57 Å
|
|
1BBC
STRUCTURE OF RECOMBINANT HUMAN RHEUMATOID ARTHRITIC SYNOVIAL FLUID PHOSPHOLIPASE A2 AT 2.2 ANGSTROMS RESOLUTION
提交 1992-05-04
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
21–144(124 aa)
|
未记录
|
未记录非水小分子
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 2.20 Å
|
|
1DB4
HUMAN S-PLA2 IN COMPLEX WITH INDOLE 8
提交 1999-11-02
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
21–144(124 aa)
|
未记录
|
CA CALCIUM ION × 2
8IN [3-(1-BENZYL-3-CARBAMOYLMETHYL-2-METHYL-1H-INDOL-5-YLOXY)-PROPYL-]-PHOSPHONIC ACID × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION;pH 7;297 K;10 MG/ML OF PROTEIN; 50 MM BUFFER (MES OR MOPS), 1% PYRIDINE, pH 7.0, VAPOR DIFFUSION, temperature 297K
|
分辨率 2.20 Å
R-free 0.256
|
|
1DB5
HUMAN S-PLA2 IN COMPLEX WITH INDOLE 6
提交 1999-11-02
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
21–144(124 aa)
|
未记录
|
CA CALCIUM ION × 2
6IN 4-(1-BENZYL-3-CARBAMOYLMETHYL-2-METHYL-1H-INDOL-5-YLOXY)-BUTYRIC ACID × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION;pH 7;297 K;10 mg/ml of protein; 50 mM buffer (MES or MOPS), 1% pyridine., pH 7.0, VAPOR DIFFUSION, temperature 297K
|
分辨率 2.80 Å
R-free 0.240
|
|
1DCY
CRYSTAL STRUCTURE OF HUMAN S-PLA2 IN COMPLEX WITH INDOLE 3 ACTIVE SITE INHIBITOR
提交 1999-11-05
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
21–144(124 aa)
|
未记录
|
CA CALCIUM ION × 2
I3N 1-BENZYL-5-METHOXY-2-METHYL-1H-INDOL-3-YL)-ACETIC ACID × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION;pH 7;297 K;10 MG/ML OF PROTEIN, 50 MM BUFFER (MES OF MOPS), 1% PYRIDINE, AN INHIBITOR
CONCENTRATION OF 1.5 MOLAR EQUIVALENT, pH 7.0, VAPOR DIFFUSION, temperature 297K
|
分辨率 2.70 Å
R-free 0.269
|
|
1J1A
PANCREATIC SECRETORY PHOSPHOLIPASE A2 (IIa) WITH ANTI-INFLAMMATORY ACTIVITY
提交 2002-12-03
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
21–144(124 aa)
链 B
21–144(124 aa)
|
未记录
|
CA CALCIUM ION × 4
BHP (S)-5-(4-BENZYLOXY-PHENYL)-4-(7-PHENYL-HEPTANOYLAMINO)-PENTANOIC ACID × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;293 K;Sodium Chloride, Calcium Chloride, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
分辨率 2.20 Å
R-free 0.258
|
|
1KQU
Human phospholipase A2 complexed with a substrate anologue
提交 2002-01-07
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
21–144(124 aa)
|
未记录
|
CA CALCIUM ION × 2
BR4 6-PHENYL-4(R)-(7-PHENYL-HEPTANOYLAMINO)-HEXANOIC ACID × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 7.8;293 K;sodium Chloride, Calcium Chloride, pH 7.8, VAPOR DIFFUSION, SITTING DROP, temperature 293.0K
|
分辨率 2.10 Å
R-free 0.240
|
|
1KVO
HUMAN PHOSPHOLIPASE A2 COMPLEXED WITH A HIGHLY POTENT SUBSTRATE ANOLOGUE
提交 1996-07-29
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
21–144(124 aa)
链 B
21–144(124 aa)
|
未记录
|
CA CALCIUM ION × 4
OAP 4-(S)-[(1-OXO-7-PHENYLHEPTYL)AMINO]-5-[4-(PHENYLMETHYL)PHENYLTHIO]PENTANOIC ACID × 2
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 2.00 Å
R-free 0.273
|
|
1KVO
HUMAN PHOSPHOLIPASE A2 COMPLEXED WITH A HIGHLY POTENT SUBSTRATE ANOLOGUE
提交 1996-07-29
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 C
21–144(124 aa)
链 D
21–144(124 aa)
|
未记录
|
CA CALCIUM ION × 4
OAP 4-(S)-[(1-OXO-7-PHENYLHEPTYL)AMINO]-5-[4-(PHENYLMETHYL)PHENYLTHIO]PENTANOIC ACID × 2
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 2.00 Å
R-free 0.273
|
|
1KVO
HUMAN PHOSPHOLIPASE A2 COMPLEXED WITH A HIGHLY POTENT SUBSTRATE ANOLOGUE
提交 1996-07-29
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 3
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 E
21–144(124 aa)
链 F
21–144(124 aa)
|
未记录
|
CA CALCIUM ION × 4
OAP 4-(S)-[(1-OXO-7-PHENYLHEPTYL)AMINO]-5-[4-(PHENYLMETHYL)PHENYLTHIO]PENTANOIC ACID × 2
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 2.00 Å
R-free 0.273
|
|
1N28
Crystal structure of the H48Q mutant of human group IIA phospholipase A2
提交 2002-10-22
|
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 B
21–144(124 aa)
|
突变:N1A, H48Q
|
CA CALCIUM ION × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.4;277 K;NaCl, CaCl2, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
分辨率 1.50 Å
R-free 0.207
|
|
1N28
Crystal structure of the H48Q mutant of human group IIA phospholipase A2
提交 2002-10-22
|
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
21–144(124 aa)
|
突变:N1A, H48Q
|
CA CALCIUM ION × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.4;277 K;NaCl, CaCl2, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
分辨率 1.50 Å
R-free 0.207
|
|
1N29
Crystal structure of the N1A mutant of human group IIA phospholipase A2
提交 2002-10-22
|
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
21–144(124 aa)
|
突变:N1A
|
CA CALCIUM ION × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;NaCl, CaCl2, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
分辨率 2.60 Å
R-free 0.320
|
|
1POD
STRUCTURES OF FREE AND INHIBITED HUMAN SECRETORY PHOSPHOLIPASE A2 FROM INFLAMMATORY EXUDATE
提交 1992-09-07
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
21–144(124 aa)
|
未记录
|
CA CALCIUM ION × 2
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 2.10 Å
|
|
1POE
STRUCTURES OF FREE AND INHIBITED HUMAN SECRETORY PHOSPHOLIPASE A2 FROM INFLAMMATORY EXUDATE
提交 1992-09-07
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
21–144(124 aa)
链 B
21–144(124 aa)
|
未记录
|
CA CALCIUM ION × 4
GEL 1-O-OCTYL-2-HEPTYLPHOSPHONYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE × 2
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 2.10 Å
|
|
3U8B
Functionally selective inhibition of Group IIA phospholipase A2 reveals a role for vimentin in regulating arachidonic acid metabolism
提交 2011-10-16
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
21–144(124 aa)
|
未记录
|
CL CHLORIDE ION × 2
CA CALCIUM ION × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.4;293 K;0.1 M Tris HCl pH 7.4, 10 mM CaCl2, 0.5 mM Beta-octyl glucoside and 4 M NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
分辨率 2.30 Å
R-free 0.257
|
|
3U8B
Functionally selective inhibition of Group IIA phospholipase A2 reveals a role for vimentin in regulating arachidonic acid metabolism
提交 2011-10-16
|
配体/离子不同
结构质量不同
|
Assembly 2
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
21–144(124 aa)
|
未记录
|
CL CHLORIDE ION × 4
CA CALCIUM ION × 4
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.4;293 K;0.1 M Tris HCl pH 7.4, 10 mM CaCl2, 0.5 mM Beta-octyl glucoside and 4 M NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
分辨率 2.30 Å
R-free 0.257
|
|
3U8D
Functionally selective inhibition of Group IIA phospholipase A2 reveals a role for vimentin in regulating arachidonic acid metabolism
提交 2011-10-16
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
21–144(124 aa)
|
未记录
|
U8D (3-{[3-(2-amino-2-oxoethyl)-1-benzyl-2-ethyl-1H-indol-5-yl]oxy}propyl)phosphonic acid × 1
CA CALCIUM ION × 2
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.4;293 K;0.1 M Tris-HCl pH 7.4, 10 mM CaCl2, 0.5 mM beta-octyl glucoside and 4 M NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
分辨率 1.80 Å
R-free 0.189
|
|
3U8D
Functionally selective inhibition of Group IIA phospholipase A2 reveals a role for vimentin in regulating arachidonic acid metabolism
提交 2011-10-16
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 B
21–144(124 aa)
|
未记录
|
U8D (3-{[3-(2-amino-2-oxoethyl)-1-benzyl-2-ethyl-1H-indol-5-yl]oxy}propyl)phosphonic acid × 1
CA CALCIUM ION × 2
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.4;293 K;0.1 M Tris-HCl pH 7.4, 10 mM CaCl2, 0.5 mM beta-octyl glucoside and 4 M NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
分辨率 1.80 Å
R-free 0.189
|
|
3U8I
Functionally selective inhibition of Group IIA phospholipase A2 reveals a role for vimentin in regulating arachidonic acid metabolism
提交 2011-10-17
|
突变/修饰不同
配体/离子不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
21–144(124 aa)
|
非标准单体:是(mmCIF未提供具体位点)
|
CA CALCIUM ION × 2
CL CHLORIDE ION × 2
NA SODIUM ION × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.4;293 K;0.1 M Tris HCl pH 7.4, 10 mM CaCl2, 0.5 mM Beta-octyl glucoside and 4 M NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
分辨率 1.10 Å
R-free 0.186
|
|
3U8I
Functionally selective inhibition of Group IIA phospholipase A2 reveals a role for vimentin in regulating arachidonic acid metabolism
提交 2011-10-17
|
突变/修饰不同
配体/离子不同
结构质量不同
|
Assembly 2
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 B
21–144(124 aa)
|
非标准单体:是(mmCIF未提供具体位点)
|
CA CALCIUM ION × 2
CL CHLORIDE ION × 2
NA SODIUM ION × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.4;293 K;0.1 M Tris HCl pH 7.4, 10 mM CaCl2, 0.5 mM Beta-octyl glucoside and 4 M NaCl, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
分辨率 1.10 Å
R-free 0.186
|
|
5G3N
Discovery of a novel secreted phospholipase A2 (sPLA2) inhibitor.
提交 2016-04-29
|
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
21–144(124 aa)
|
突变:YES
|
CA CALCIUM ION × 2
FMT FORMIC ACID × 1
X28 3-(5'-BENZYL-2'-CARBAMOYLBIPHENYL-3-YL)PROPANOIC ACID × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
3.0-3.5M SODIUM FORMATE AND 100MM HEPES PH 7.5
|
分辨率 1.80 Å
R-free 0.231
|
|
5G3N
Discovery of a novel secreted phospholipase A2 (sPLA2) inhibitor.
提交 2016-04-29
|
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 B
21–144(124 aa)
|
突变:YES
|
CA CALCIUM ION × 2
FMT FORMIC ACID × 1
X28 3-(5'-BENZYL-2'-CARBAMOYLBIPHENYL-3-YL)PROPANOIC ACID × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
3.0-3.5M SODIUM FORMATE AND 100MM HEPES PH 7.5
|
分辨率 1.80 Å
R-free 0.231
|